InvestorsHub Logo
Followers 37
Posts 2257
Boards Moderated 0
Alias Born 05/10/2016

Re: None

Wednesday, 12/30/2020 11:32:04 PM

Wednesday, December 30, 2020 11:32:04 PM

Post# of 199527
One of the more exciting news bits in today's PR is where Charles addresses the Covid19 variant that first surfaced in Great Britain last week and is spreading 70% faster than Covid19. ENZC is way ahead of other companies to come up with an efficacious solution. ENZC has the unique technology to bind on an immutable protein spike, thus preventing viral escape.

Charles stated in today's PR:
"We have all now heard of the new variants of the CoronaVirus that have just surfaced this week in the United Kingdom and South Africa. Such variants have been found to now exist in the U.S. Due to mutation, these variants have slightly different structures from the virus as initially introduced into the U.S. and will require different therapeutics to address them. The necessary response to such mutations is to identify sites on the virus that do not mutate - that are immutable - and to produce monoclonal antibodies targeting these immutable sites. Using artificial intelligence, we expect to be able to identify these sites such that antibodies may be produced targeting them. This is one of our focuses."